You May Also Like

Yellow fever vaccine.
Cite
CITE Title : Yellow fever vaccine. Personal Author(s) : Arya, S. C. Published Date : 1999 May-Jun Source : Emerg Infect Dis. 5(3):487-489. URL : https://stacks.cdc.gov/view/cdc/14865
• File Format:
Copy Export
• RIS
[PDF - 53.44 KB]
Personal Author:
Arya, S. C.
1999 May-Jun | Emerg Infect Dis. 5(3):487-489.
No Description
File Type:
[PDF - 53.44 KB]
File Type:
[PDF - 53.44 KB]

Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018–2019 Season
Cite
CITE Title : Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018–2019 Season Personal Author(s) : Perez-Vilar, Silvia;Hu, Mao;Weintraub, Eric;Arya, Deepa;Lufkin, Bradley;Myers, Tanya;Woo, Emily Jane;Lo, An-Chi;Chu, Steve;Swarr, Madeline;Liao, Jiemin;Wernecke, Michael;MaCurdy, Tom;Kelman, Jeffrey;Anderson, Steven;Duffy, Jonathan;Forshee, Richard A.; Published Date : 2 13 2021 Source : J Infect Dis. URL : https://stacks.cdc.gov/view/cdc/103505
• File Format:
Copy Export
• RIS
[PDF - 580.85 KB]
Personal Author:
Perez-Vilar, Silvia ;
Hu, Mao
...
2 13 2021 | J Infect Dis.
Description:
Background.The Vaccine Safety Datalink (VSD) identified a statistical signal for an increased risk of Guillain-Barré syndrome (GBS) in days 1–42 af...
File Type:
[PDF - 580.85 KB]
File Type:
[PDF - 580.85 KB]